Two crossed lines that form an 'X'. It indicates a way to close an interaction, or dismiss a notification.
This story was delivered to Business Insider Intelligence Digital Health Pro subscribers earlier this morning. To get this story plus others to your inbox each day, hours before they're published on Business Insider, click here. The Swiss pharmaceutical titan is embarking on a multiyear alliance with Amazon's cloud-computing business — Amazon Web Services — to leverage AI, data analytics, and cloud-based "Insight Centers" to revamp the many steps involved in drug manufacturing, FierceBiotech This marks the latest team-up for Novartis in its race to digitize and streamline all phases of its operations — an initiative spearheaded by Chief Digital Officer Bertrand Bodson, a former Amazon leader who AWS is...
Novartis is leaning on AWS' data analytics prowess and predictive AI capabilities to better produce hard-to-develop drugs, which could pave the way for the faster development of more personalized meds. Novartis is diving into cell and gene therapy development, but these sorts of treatments are incredibly complex to produce since they're custom to each patient — meaning development hinges on mining through tons of data.
Hopefully GIS and location intelligence is a big part of the foundation, since cloud is just a portal.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
ソース: BusinessInsider - 🏆 729. / 51 続きを読む »
ソース: BusinessInsider - 🏆 729. / 51 続きを読む »
ソース: BusinessInsider - 🏆 729. / 51 続きを読む »
ソース: BusinessInsider - 🏆 729. / 51 続きを読む »